Novo Nordisk (NVO) Gets Positive CHMP Opinion for Wegovy Posted byZacks Equity Research November 12, 2021 Leave a comment on Novo Nordisk (NVO) Gets Positive CHMP Opinion for Wegovy The CHMP gives a positive opinion on, and recommends approval to Novo Nordisk’s (NVO) Wegovy for chronic weight management in adults with obesity.